Skip survey header

SO2023780 - BCaMonitor - Case 1 - Question 2

Henry with intermediate-risk NMIBC finds follow-up cystoscopies burdensome. What now?

Henry, 70 years old, used to work as a creative director in a chocolate factory. Once, he designed chocolates that looked like broccoli. Too bad, they were not favoured by the clients…

He was initially diagnosed with a solitary small Ta low-grade (LG) tumour. He received 1 immediate chemotherapy instillation after transurethral resection of the bladder tumour (TURBT).

Follow-up cystoscopy after 6 months shows a 1 cm papillary tumour and TURBT is performed. Visual appearance suggests a low grade and he received again 1 immediate chemotherapy instillation. The pathology report confirms urothelial cancer pTa LG (muscle in specimen, no LVI).

He received mitomycin C instillations for 1 year. In the meantime, no recurrences were detected during follow-up.

His follow-up visit at 12 months post-TURBT: 
•    Cystoscopy: negative
•    Cytology: negative

The patient indicated he finds multiple cystoscopies burdensome.
 
In case the patient refused to continue with cystoscopic follow-up altogether, which option for surveillance would you propose to this patient (assuming all of the below options are available and fully covered for the patient)?
** perform cystoscopy only following symptoms, such as haematuria